RDD1609 as a Treatment for Idiopathic Pruritus Ani

NCT03757403 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Covid-19

Conditions

Idiopathic Pruritus Ani

Interventions

DRUG: RDD1609
DRUG: Mebendazole 100 MG

Sponsor

RDD Pharma Ltd